KOWIT-YU CHONG et al. found that oncostatin M-preconditioned MSCs improved pulmonary function, reduced inflammatory and fibrotic mediators in bleomycin-Induced pulmonary fibrosis models through hepatocyte growth factor [13]. This evidence concerns the gene HGF and pulmonary fibrosis.